Current role
Biotechnology · Healthcare
Board Member
2026-06-12–present
Dr. Matt Cohen, M.D., M.B.A.
Board Member
Arrowhead Pharmaceuticals, Inc. (ARWR)Equibles does not estimate personal net worth.
Get an email with a short summary when Arrowhead Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARWR alertsAbout Dr. Matt Cohen, M.D., M.B.A.
Dr. Matt Cohen, M.D., M.B.A. is recorded as Board Member at Arrowhead Pharmaceuticals, Inc. (ARWR) since June 12, 2026. Arrowhead Pharmaceuticals, Inc. reported in an 8-K filed June 16, 2026 that Dr. Matt Cohen, M.D., M.B.A. was appointed director, effective June 12, 2026. Arrowhead Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arrowhead Pharmaceuticals, Inc. includes Christopher Anzalone (CEO and Board Member), Daniel Apel (CFO), Patrick O'Brien (COO) and 6 others.
“On June 12, 2026, the Board of Directors of Arrowhead Pharmaceuticals, Inc. (the "Company") appointed Dr. Matt Cohen, M.D., M.B.A., as a director of the Company, effective June 12, 2026.”
Affiliation history
-
Current
2026-06-12–present
Company network
Leadership on record at Arrowhead Pharmaceuticals, Inc.
- Christopher Anzalone CEO, Board Member
- Daniel Apel CFO
- Patrick O'Brien COO
- Patrick O’Brien COO, General Counsel
- Douglas Ingram Board Member
- Hongbo Lu Board Member
- Hongbo Lu, Ph.D. Board Member
- Oye Olukotun, M.D., MPH Board Member
- Victoria Vakiener Board Member